ARTICLE | Clinical News
Tuberculosis: Preliminary Phase I data
March 19, 2007 7:00 AM UTC
Preliminary data from an open-label, Dutch Phase I trial in 36 healthy volunteers showed that ICLL's TB vaccine was safe and stimulated a strong immunogenic T cell response. ...